The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study. (14th November 2020)

• Record Type: Journal Article
• Authors: Wu, Dongze; Wong, Priscilla; Lam, Steven H M; Li, Edmund K; Qin, Ling; Tam, Lai-Shan; Gu, Jieruo
• Is Part Of: Rheumatology. Volume 60:Number 4(2021)
• Page Start: 1963
• Page End: 1973
• Publication Date: 2020-11-14
• Subjects: psoriatic arthritis -- interleukin-17 -- Mendelian randomization -- tumour necrosis factor-α -- interleukin-12p70; Rheumatism -- Periodicals; Rheumatology -- Periodicals; 616.723005
• DOI: 10.1093/rheumatology/keaa629
• Languages: English
• ISSNs: 1462-0324

Abstract

Abstract: Objective: To determine causal associations between genetically predicted TNF-α, IL-12p70 and IL-17 levels and risk of PsA. Methods: The publicly available summary-level findings from genome-wide association studies (GWAS) was used to identify loci influencing normal physiological concentrations of TNF-α, IL-12p70 and IL-17 ( n = 8293) among healthy individuals as exposure and a GWAS for PsA from the UK Biobank (PsA = 900, control = 462 033) as the outcome. A two-sample Mendelian randomization (MR) analysis was performed using the inverse-variance weighted (IVW), weighted median and MR–Egger regression methods. Sensitivity analysis and MR–Egger regression analysis were performed to evaluate the heterogeneity and pleiotropic effects of each variant. Results: Single-nucleotide polymorphisms (SNPs) at genome-wide significance from GWASs on TNF-α, IL-12p70 and IL-17 were identified as the instrumental variables. The IVW method indicated a causal association between increased IL-17 level and risk of PsA (β = −0.00186 per allele, s .e . = 0.00043, P = 0.002). Results were consistent in the weighted median method (β = −0.00145 per allele, s .e . = 0.00059, P = 0.014) although the MR–Egger method suggested a non-significant association (β = −0.00133 per allele, s .e . = 0.00087; P = 0.087). Single SNP MR results revealed that the C allele of rs117556572 was robustly associated with risk of PsA (β = 0.00210, s .e . = 0.00069, P = 0.002). However, no evidence for a causal effect was observed between TNF-α, IL-12p70, decreased IL-17 levels and risk of PsA. Conclusion: Our findings provide preliminary evidence that genetic variants predisposing to higher physiological IL-17 level are associated with decreased risk of PsA.